PhotonPharma adds ex-Sanofi VP to board

FORT COLLINS — PhotonPharma Inc., which specializes in tumor-specific immune therapies, recently added William Warren to its board of directors. 

Warren was most recently a vice president and head of innovation within the vaccine division at French pharmaceutical giant Sanofi SA. Prior to that he was CEO and co-founder of VaxDesign Corp.

“I am excited to join PhotonPharma’s board at this pivotal time in the company’s evolution,” Warren said in a prepared statement. “The company’s innovative approach to autologous cancer therapies represents exactly the kind of transformative technology that can address critical unmet medical needs. I look forward to leveraging my experience in building and scaling innovative biotechnology platforms to help PhotonPharma achieve its ambitious goals.”

Share on Facebook on LinkedIn